Farnesyl protein transferase inhibitors as antitumor agents
US7557107B2 · kind B2 · utility
2Cited by
1References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2004 |
| Grant date | Jul 7, 2009 |
| Priority date | — |
| Expiry date | Sep 25, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel tricyclic compounds of the formula:and a pharmaceutically acceptable salts or solvates thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising the compounds of formula (I). Also disclosed are uses of the compounds of formula (I) for the manufacture of a medicament for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.